| Application no. and date | 18814821.7 (espacenet) (Federated) (European Patent Register), 20181129 | | Patent/reg. no. and date | DK/EP 3716979, 20250409 | | Publication date | 20201007 | | Priority no. and date | WO PCT/EP2017/081050, 20171130 | | EP pub. no. and date |
EP 3716979 20201007 | | Effective date | | | Applicant/owner | Idorsia Pharmaceuticals Ltd, Hegenheimermattweg 91
4123 Allschwil, CH | | Applicant ref. no. | P86423DK01 | | Inventor | BELLET, Marc, c/o Idorsia Pharmaceuticals Ltd
Hegenheimermattweg 91
4123 Allschwil, CH,
IGLARZ, Marc, c/o Idorsia Pharmaceuticals Ltd
Hegenheimermattweg 91
4123 Allschwil, CH | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 31/506 (2006.01) , A61K 31/70 (2006.01) , A61K 31/7042 (2006.01) , A61K 31/7048 (2006.01) , A61K 31/7056 (2006.01) , A61P 13/12 (2006.01) , A61P 17/02 (2006.01) , A61P 3/10 (2006.01) , A61P 9/10 (2006.01) , A61P 9/12 (2006.01) | | Title | KOMBINATION AF ET 4-PYRIMIDINSULFAMIDDERIVAT MED EN SGLT-2-INHIBITOR TIL BEHANDLINGEN AF ENDOTHELINRELATEREDE SYGDOMME | | Int. application no. | EP2018082947 | | Int. publication no. | WO2019106066 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
